professionaladviser_logo

FOR SUSTAINABLE, PROFITABLE, CLIENT-FOCUSED ADVISER FIRMS

pin Sign in Join
pin
    • My account
    • Sign out
  • You are currently accessing Professional Adviser via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0) 1858 438800

    Email: [email protected]

    • Sign in
logo
  • logo

    Search Professional Adviser

  • News
  • More

    Choose from below

    • Features
    • Opinion
    • Editor's View
    • People Moves
    • Market Movers
    • Feel Good Friday
    • Professional Adviser TV
  • Your Business
    • Recruitment
    • Platforms
    • MPS
    • Education
    • Technology
    • Paraplanning
    • Diversity
    • Succession planning
  • Your Profession
    • Pensions
    • Investment
    • Regulation
    • ESG
    • Protection
    • Estate planning
    • Tax planning
    • Retirement
  • Consumer Duty
  • Events
  • About

    Authors

    • Jen Frost
    • Jenna Brown
    • Sahar Nazir
    • Isabel Baxter

    Featured Content

    • Cost of Living
    • Partner Insight
    • InvestmentIQ
    • PA360 Watchlist

    Sister publications

    • BusinessGreen
    • COVER
    • Investment Week
    • Professional Pensions

    Incisive Media

    • Our company
    • Careers
  • Searchlogo

    Search Professional Adviser

    x
Join Sign in
 
    • My account
    • Sign out
  • You are currently accessing Professional Adviser via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0) 1858 438800

    Email: [email protected]

    • Sign in
    • Sign in

healthcare

PMI

NICE rejects breast cancer drug

The National Institute for Health and Clinical Excellence (NICE) has rejected another cancer drug for the NHS due to its cost.

clock 22 August 2011 •

PMI

NHS meets all cancer targets

The NHS exceeded all seven of its targets for cancer diagnosis and treatment during the last year, new data has revealed.

clock 19 August 2011 •

PMI

Govt launches second NHS listening exercise

The NHS Future Forum is to conduct a second stage of its listening exercise following a request by the government to assess its revised proposals.

clock 18 August 2011 •

Long Term Care

Old people face reduced care from personal budgets - Laing & Buisson

Older people taking up personal budgets often face cuts to the level of care they can afford and are forced to do so because it is the only way they can continue to use their familiar care worker, according to new research.

clock 17 August 2011 •

PMI

NHS reports £1.5bn surplus ahead of increasing pressure

The NHS is in good financial health after producing a surplus of £1.5bn over the last financial year but it faces a stiff challenge over the coming years.

clock 11 August 2011 •

PMI

More NHS services open for private providers - report

More NHS services are set to be run by private companies after it was revealed that nine more primary care trusts (PCTs) are planning or are in the process of putting entire care pathways out to tender.

clock 10 August 2011 •

PMI

Groupama defends healthcare sale as PMI revenue grows

Groupama has seen its healthcare business revenues grow over the first six months of the year and further discussed its decision, announced this week, to sell the business.

clock 05 August 2011 •

PMI

Bupa knee op reviews 'not supported' by Royal College of Surgeons

The Royal College of Surgeons (RCS) has said it does not support Bupa's medical reviews for knee surgery because it has no input or control over the process.

clock 02 August 2011 •

PMI

Bupa adds new direct PMI offering

Bupa has launched a new private medical insurance (PMI) product on to the direct market.

clock 01 August 2011 •

PMI

AMII condemns 'regrettable' NHS waiting list tactics

The Association of Medical Insurance Intermediaries (AMII) has called revelations of NHS Trusts using cost cutting tactics that result in patients dying or force them into private treatment as "a cynical approach" and "regrettable".

clock 29 July 2011 •
111213
  • Contact Us
  • Marketing Solutions
  • About Incisive Media
  • Privacy Settings
  • Careers
  • Terms & Conditions
  • Policies
FOLLOW US
Incisive Media

© Incisive Business Media Limited, Published by Incisive Business Media Limited, New London House, 172 Drury Lane, London WC2B 5QR. Registered in England and Wales with company registration number 09178013. Part of Arc network, www.arc-network.com

DIGITAL PUBLISHER OF THE YEAR
right wallpaper ad
Loading.gif?page type=listing page&tag=healthcare